Sort
48,018 grants matching “immunotherapy”
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2023 · AI
SPORE in Brain Cancer
$2,042,322Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
EVALUATION OF THE IMMUNOGENICITY AND EFFICACY OF HIV-1 CLADE C OLIGOMERIC ENVELOPE PROTEIN DELIVERED WITH ADVAX DELTA INULIN ADJUVANT BY INTRAMUSCULAR AND INTRAPULMONARY ROUTES
$2,041,729Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$2,040,477Ohio State University · U01 · FY2002 · AI
Targeting the DNA damage response in cancer therapy
$2,040,170Travis Stracker · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
T cell effector and regulatory mechanisms in asthma and food allergy
$2,039,617Andrew D Luster · Massachusetts General Hospital · U19 · FY2011 · AI
Growth Factor Imaging and Photoimmunotherapy
$2,038,697Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Melanoma and Skin Cancer Program SPORE
$2,037,632Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2021 · CA
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$2,037,244Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION
$2,037,176Massachusetts General Hospital · U01 · FY2005 · AI
Duke SPORE in Brain Cancer
$2,036,564John H Sampson · Duke University · P50 · FY2016 · CA
Specialized Program Of Research Excellence (SPORE) in Leukemia.
$2,035,962Daniel C Link · Washington University · P50 · FY2021 · CA
Vector-pathogen-host interaction and immunopathogenesis of disease progression
$2,035,617Tais Saito · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
NYU Melanoma SPORE
$2,035,150Iman Osman · New York University School Of Medicine · P50 · FY2022 · CA
Immunologic Approaches to Ovarian Cancer
$2,033,832Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
Immunologic Approaches to Ovarian Cancer
$2,033,832David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Immunologic Approaches to Ovarian Cancer
$2,033,832Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2018 · CA
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$2,033,275Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2025 · AR
Identifying Metabolic Vulnerabilities in Lung Cancer
$2,032,950Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2025 · CA
TCR Gene Modified T Cells for Adoptive Immunotherapy
$2,032,647Michael I Nishimura · Loyola University Chicago · P01 · FY2011 · CA
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$2,032,638Peter Karl Sorger · Harvard Medical School · U54 · FY2021 · CA
DNA Sequencing and FACS Core Facilities
$2,031,947Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Induction and maintenance of regulatory T cells
$2,031,918Mitchell Kronenberg · La Jolla Institute For Immunology · P01 · FY2014 · AI
Induction and maintenance of regulatory T cells
$2,031,918Mitchell Kronenberg · La Jolla Institute For Immunology · P01 · FY2012 · AI
Mayo Clinic Multiple Myeloma SPORE
$2,031,615Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2022 · CA